Anthropic says Claude used for cyberattacks and surveillance
Joseph K. Schachle, Chief Operating Officer at Opus Genetics, Inc. (), recently sold 4,644 shares of the company’s common stock. The transaction, totaling $13,653, occurred on July 23, 2026, with shares sold at a price of $2.94 each. The stock
